Saturday 17 October 2026
Export LH’s income statement to Excel — free account
Labcorp Holdings Inc.
LH Healthcare Diagnostics & Research
Labcorp Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.0 billion, up 7.25% from fiscal 2024. In the quarter to June 2026, revenue grew 5.78%, EPS grew 28.4%, free cash flow fell 42.0% and total debt rose 15.1%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for five consecutive years, revenue growth for three.
318.66
6.41
−1.97%
Follow LH
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 11.74% | 11.05% | 10.51% | 10.14% |
+8 more TTM periods Free account |
|
Piotroski F-Score |
8 | 7 | 8 | 9 | |
| 5.48% | 5.13% | 4.77% | 4.64% | ||
ROIC |
6.50% | 6.59% | 6.54% | 6.29% | |
Return on Tangible Assets |
20.92% | 18.89% | 20.49% | 18.74% | |
Average Days of Receivables |
63.72 | 63.24 | 59.14 | 60.06 | |
Free Cash Flow per Share |
14.33 | 17.00 | 14.59 | 16.68 | |
Free Cash Flow |
1,170.50 | 1,399.30 | 1,214.00 | 1,385.70 | |
Capital Expenditures |
(467.90) | (414.20) | (426.50) | (417.80) | |
| Other line items | |||||
Cash ROIC |
7.98% | 8.97% | 8.49% | 9.60% | |
Accounts Receivable Turnover |
6.00 | 5.99 | 6.40 | 6.13 | |
Accounts Payable Turnover |
13.78 | 14.24 | 11.58 | 14.82 | |
Inventory Turnover |
19.07 | 20.42 | 19.34 | 19.61 | |
Average Days of Payables |
24.63 | 25.23 | 30.88 | 24.77 | |
Days of Inventory on Hand |
20.11 | 18.05 | 19.64 | 19.33 | |
Tax Rate |
(0.19) | (0.18) | (0.21) | (0.22) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
15.47% | 15.70% | 15.89% | 16.51% | |
Share Based Compensation of Revenue |
0.87% | 0.88% | 0.90% | 0.90% | |
Interest Coverage |
6.59 | 6.45 | 6.18 | 5.74 | |
Operating CF/Net income |
1.63 | 1.93 | 1.87 | 2.11 | |
Depreciation/Fixed assets |
0.22 | 0.22 | 0.22 | 0.22 | |
Capex/Depreciation |
(0.67) | (0.60) | (0.63) | (0.62) | |
Revenue per Share |
175.62 | 171.86 | 167.69 | 165.65 | |
Operating CF per Share |
20.05 | 22.04 | 19.72 | 21.70 | |
Capex per Share |
(5.73) | (5.03) | (5.13) | (5.03) | |
Capex to Sales |
0.03 | 0.03 | 0.03 | 0.03 |
Columns are period end dates